US Business
Medical Device Makers Seek Priority in Chip Shortage
Manufacturers of pacemakers, ultrasound machines and other medical devices emphasize their life-saving products to secure supply of computer chips.
Month: October 2021
US Business
Democrats’ Tax Plans Worry High-Income Businesses
Most closely held businesses won’t face higher taxes, but bigger, more profitable companies could see their costs swell.
US Business
Tesla Deliveries Surge, Defying Supply-Chain Woes
The electric-vehicle maker provided a record number of vehicles in third quarter amid flagging global auto sales.
US Business
‘Squid Game’ Is the Dystopian Netflix Hit No One Wanted—Until Everyone Did
The South Korean phenomenon might become Netflix’s biggest hit ever, but for a decade, local studios rejected the show’s pitch as too grotesque and too unrealistic.
US Business
Holiday-Travel Bookings Are Growing Tight, Driving Up Prices
A rush of people booking holiday travel is driving up prices and lowering inventory. Advisers says Americans who have been holding out should make plans soon.
US Business
Bud Light Maker Tries Again With Hard Seltzer
Anheuser-Busch after several false starts—and with what management says is a new mind-set—hopes it’s not too late to tap what has been a growth market.
US Business
Apple Doesn’t Make Videogames. But It’s the Hottest Player in Gaming.
CEO Tim Cook quietly turned the iPhone company into a superpower in the videogame business. Now he’s fighting rivals in a multiplayer universe.
US Business
Toyota Outsells GM in U.S. for Second Quarter in a Row
The Japanese auto maker has overtaken rival GM in U.S. sales for the third quarter and first nine months of the year, illustrating the disproportionate impact of the chip shortage.
Education
Global Leaders Pinning Ceremony, Speaker Series Planned
(Joplin, MO) – A pinning ceremony and the launch of a new speaker series are among the upcoming events planned for students in the inaugural Global Leaders cohort at Missouri Southern State University. Launched at […]
US Business
Merck Pill Intended to Treat Covid-19 Succeeds in Key Study
The drug from Merck and Ridgeback Biotherapeutics cut the risk of hospitalization or death among subjects by 50% in an early look at the study’s progress.